SEARAINBOW(SZ:000503) 中国基金报·2025-09-04 11:49Core Viewpoint - The article reports the passing of Bai Yan, an independent director of Guo Xin Health, due to illness, highlighting his contributions and the company's plans for board member replacement [1][3][4]. Summary by Sections Announcement of Passing - Guo Xin Health announced the death of independent director Bai Yan on August 31, 2025, due to illness [1][3]. - Bai Yan served as the chairman of the Compensation and Assessment Committee and was a member of the Audit and Nomination Committees [1]. Contributions and Legacy - Bai Yan was recognized for his diligence and commitment to his duties, providing professional opinions and safeguarding the interests of minority shareholders during his tenure [3]. - The company expressed deep condolences and gratitude for Bai Yan's efforts and contributions [3]. Board Composition Changes - Following Bai Yan's passing, the board's membership decreased from 9 to 8, remaining above the legal minimum but below the number stipulated in the company's articles of association [3]. - Guo Xin Health plans to conduct a replacement for the independent director in accordance with relevant regulations [3]. Background of Bai Yan - Bai Yan, aged 60, held a Ph.D. from Peking University and had a distinguished academic and professional career, including roles as a professor and external director in various organizations [4]. - He was noted for his integrity, optimism, and contributions to academia and society [4].